Tenet Healthcare (NYSE:THC) Price Target Raised to $304.00

Tenet Healthcare (NYSE:THC) had its price objective boosted by Royal Bank Of Canada from $283.00 to $304.00 in a research note published on Monday,Benzinga reports. The firm currently has an outperform rating on the stock.

THC has been the topic of a number of other research reports. Leerink Partners restated an “outperform” rating and set a $309.00 price objective on shares of Tenet Healthcare in a research report on Friday, September 18th. Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 17th. UBS Group upped their price objective on Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a research note on Monday, July 27th. Guggenheim cut their target price on shares of Tenet Healthcare from $307.00 to $306.00 and set a “buy” rating on the stock in a research report on Friday, October 30th. Finally, Stephens reiterated an “overweight” rating and set a $285.00 target price on shares of Tenet Healthcare in a research report on Monday, July 27th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $293.48.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $291.26 on Monday. Tenet Healthcare has a fifty-two week low of $157.58 and a fifty-two week high of $294.11. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.58 and a quick ratio of 1.52. The firm has a market capitalization of $23.18 billion, a P/E ratio of 8.45, a P/E/G ratio of 1.43 and a beta of 1.20. The company’s 50 day moving average price is $264.75 and its two-hundred day moving average price is $221.49.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, October 29th. The company reported $6.64 earnings per share for the quarter, topping analysts’ consensus estimates of $4.68 by $1.96. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The firm had revenue of $6.28 billion for the quarter, compared to analysts’ expectations of $5.49 billion. During the same quarter in the previous year, the firm posted $3.70 earnings per share. The company’s revenue was up 6.5% on a year-over-year basis. On average, equities analysts forecast that Tenet Healthcare will post 22.32 earnings per share for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In other news, CEO Saumya Sutaria sold 50,000 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $278.71, for a total value of $13,935,500.00. Following the completion of the sale, the chief executive officer owned 483,564 shares of the company’s stock, valued at approximately $134,774,122.44. This represents a 9.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Lisa Y. Foo sold 24,000 shares of the firm’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $266.32, for a total value of $6,391,680.00. Following the transaction, the executive vice president owned 8,053 shares of the company’s stock, valued at $2,144,674.96. This trade represents a 74.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 100,962 shares of company stock worth $27,440,309 over the last 90 days. Company insiders own 0.97% of the company’s stock.

Institutional Trading of Tenet Healthcare

Institutional investors have recently added to or reduced their stakes in the stock. Manning & Napier Advisors LLC bought a new stake in Tenet Healthcare in the second quarter worth approximately $168,761,000. Arrowstreet Capital Limited Partnership lifted its stake in Tenet Healthcare by 57.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company’s stock valued at $126,757,000 after buying an additional 244,901 shares during the period. Bank of New York Mellon Corp bought a new position in shares of Tenet Healthcare during the 2nd quarter worth approximately $106,342,000. Empowered Funds LLC boosted its holdings in shares of Tenet Healthcare by 22.1% during the 1st quarter. Empowered Funds LLC now owns 284,753 shares of the company’s stock worth $53,736,000 after buying an additional 51,549 shares in the last quarter. Finally, Hsbc Holdings PLC grew its position in shares of Tenet Healthcare by 3,478.7% during the 4th quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock worth $53,269,000 after buying an additional 258,956 shares during the period. 95.44% of the stock is currently owned by institutional investors.

More Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported quarterly EPS of $6.64, topping the $4.68 consensus estimate, and revenue of $6.28 billion versus expectations of $5.49 billion. Revenue increased 6.5% year over year. Tenet Healthcare stock after Q3: 2026 EBITDA outlook raised
• Positive Sentiment: Management raised its 2026 EBITDA outlook, adding to investor optimism about the company’s earnings prospects. Tenet Healthcare stock after Q3: 2026 EBITDA outlook raised
• Positive Sentiment: Barclays raised its price target to $297 from $271 and maintained an “overweight” rating. Truist reaffirmed “buy” and raised its target to $305 from $290, while KeyCorp lifted its target to $300 from $270 and retained “overweight” coverage.
• Positive Sentiment: Wells Fargo, Leerink Partners, and Royal Bank of Canada were also cited as expecting further appreciation in THC shares. Read More., Read More., Read More.
• Neutral Sentiment: Zacks noted increased investor attention to Tenet, but its article focused on factors to consider rather than announcing a specific rating or forecast change. Tenet Healthcare Is a Trending Stock

About Tenet Healthcare

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.